These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1835742)

  • 41. [Comment on the contribution: "Effect of omeprazole on serum gastrin levels: influence of age and sex" by Koop et al].
    Miederer SE
    Z Gastroenterol; 1991 Apr; 29(4):177-8. PubMed ID: 1866976
    [No Abstract]   [Full Text] [Related]  

  • 42. Clinical experience with omeprazole: assessment of efficacy and safety.
    Walan A
    J Gastroenterol Hepatol; 1989; 4 Suppl 2():27-33. PubMed ID: 2491359
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Daily low-dose versus alternate day full-dose lansoprazole in the maintenance treatment of reflux esophagitis.
    Baldi F; Morselli-Labate AM; Cappiello R; Ghersi S;
    Am J Gastroenterol; 2002 Jun; 97(6):1357-64. PubMed ID: 12094850
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Generous treatment with gastric acid blockers. For patients with gastric reflux the proton pump inhibitor power is cost-effective].
    MMW Fortschr Med; 2003 Feb; 145(6):56-7. PubMed ID: 12619364
    [No Abstract]   [Full Text] [Related]  

  • 45. Lansoprazole: a comprehensive review.
    Zimmermann AE; Katona BG
    Pharmacotherapy; 1997; 17(2):308-26. PubMed ID: 9085323
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Omeprazole and acid peptic disease.
    Piper DW; Yeomans ND; Shearman DJ
    Med J Aust; 1991 Mar; 154(6):374-5. PubMed ID: 2000048
    [No Abstract]   [Full Text] [Related]  

  • 47. Effect of omeprazole and high doses of ranitidine on gastric acidity and gastroesophageal reflux in patients with moderate-severe esophagitis.
    Fiorucci S; Santucci L; Morelli A
    Am J Gastroenterol; 1990 Nov; 85(11):1458-62. PubMed ID: 2239873
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Low-dose omeprazole for erosive esophagitis.
    Epling J; Taylor H
    J Fam Pract; 1999 Feb; 48(2):93-4. PubMed ID: 10037536
    [No Abstract]   [Full Text] [Related]  

  • 49. Safety experience from long-term treatment with omeprazole.
    Joelson S; Joelson IB; Lundborg P; Walan A; Wallander MA
    Digestion; 1992; 51 Suppl 1():93-101. PubMed ID: 1397750
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The safety of omeprazole: true or false?
    Sachs G
    Gastroenterology; 1994 May; 106(5):1400-1. PubMed ID: 8174907
    [No Abstract]   [Full Text] [Related]  

  • 51. [The omeprazole treatment of patients with diseases of the upper digestive tract].
    Degtiareva II; Zukheĭr Kh; Lodianaia EV; Palladina OL; Nevstruev VP; Piletskiĭ AM; Chervak IN
    Lik Sprava; 1994; (7-8):117-20. PubMed ID: 7900331
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Optimal use of acid-inhibitors in acid-related diseases. Physiological and physiopathological considerations with implications on therapeutic choice].
    Waldum HL
    Tidsskr Nor Laegeforen; 1993 Feb; 113(4):465-9. PubMed ID: 8465291
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Advances in the knowledge of peptic-acid dependent diseases].
    Mazure PA; Pigliacampo J
    Acta Gastroenterol Latinoam; 1989; 19(3):165-73. PubMed ID: 2576850
    [No Abstract]   [Full Text] [Related]  

  • 54. Qualitative studies of gastric endocrine cells in patients treated long-term with omeprazole.
    Solcia E; Rindi G; Havu N; Elm G
    Scand J Gastroenterol Suppl; 1989; 166():129-37; discussion 138-9. PubMed ID: 2513643
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Effect of FOY-305 on post-operative reflux esophagitis in rats (II). Analysis of mechanism in the pathogenesis of reflux esophagitis after total gastrectomy in rats].
    Kamiyasu K; Inoshiri S; Omawari N; Okegawa T; Kawasaki A
    Nihon Yakurigaku Zasshi; 1991 May; 97(5):251-7. PubMed ID: 1879803
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Omeprazole in short term treatment of reflux oesophagitis.
    Jafri W; Abbas Z; Hamid S; Abid S; Shah H; Khan H
    J Pak Med Assoc; 1992 Dec; 42(12):290-2. PubMed ID: 1299735
    [No Abstract]   [Full Text] [Related]  

  • 57. Omeprazole and ultrastructural modifications occurring in reflux esophagitis.
    Calabrese C; Areni A; Miglioli M; DiFebo G
    Gastroenterology; 2002 Mar; 122(3):837. PubMed ID: 11878295
    [No Abstract]   [Full Text] [Related]  

  • 58. [Effects of FOY-305 on post-operative reflux esophagitis in rats (I). Effects of FOY-305 on reflux esophagitis after total gastrectomy in rats].
    Kamiyasu K; Awata H; Inoshiri S; Doi A; Omawari N; Okegawa T; Kawasaki A; Shinomiya K; Tanaka M; Suzuki Y
    Nihon Yakurigaku Zasshi; 1991 May; 97(5):241-9. PubMed ID: 1879802
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Omeprazole.
    Lancet; 1987 Dec; 2(8573):1467. PubMed ID: 2892029
    [No Abstract]   [Full Text] [Related]  

  • 60. Optimal dose of omeprazole in infants and children.
    Alliët P; Raes M; Gillis P; Zimmermann A
    J Pediatr; 1994 Feb; 124(2):332-4. PubMed ID: 8301451
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.